 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$40.53 |
$40.86 |
$38.56 |
$39.25 |
498.00K | | 04/15/2024 |
$39.44 |
$40.12 |
$38.69 |
$39.07 |
409.40K | | 04/16/2024 |
$39.03 |
$39.27 |
$38.14 |
$38.60 |
722.60K | | 04/17/2024 |
$39.01 |
$40.45 |
$38.67 |
$39.63 |
954.90K | | 04/18/2024 |
$39.41 |
$39.94 |
$38.29 |
$38.53 |
576.60K |
|
|
| Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors. | |
|
Celldex Therapeutics (CLDX) has the following price history information. Looking back at CLDX historical stock prices for the last five trading days, on April 12, 2024, CLDX opened at $40.53, traded as high as $40.86 and as low as $38.56, and closed at $39.25. Trading volume was a total of 498.00K shares. On April 15, 2024, CLDX opened at $39.44, traded as high as $40.12 and as low as $38.69, and closed at $39.07. Trading volume was a total of 409.40K shares. On April 16, 2024, CLDX opened at $39.03, traded as high as $39.27 and as low as $38.14, and closed at $38.60. Trading volume was a total of 722.60K shares. On April 17, 2024, CLDX opened at $39.01, traded as high as $40.45 and as low as $38.67, and closed at $39.63. Trading volume was a total of 954.90K shares. On April 18, 2024, CLDX opened at $39.41, traded as high as $39.94 and as low as $38.29, and closed at $38.53. Trading volume was a total of 576.60K shares.
CLDX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Celldex Therapeutics shares, starting with a $10,000 purchase of CLDX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$240.15 |
|
| End price/share: |
$38.53 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-83.96% |
|
| Average Annual Total Return: |
-16.73% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,603.63 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/12/2024 | $39.25 | | 04/15/2024 | $39.07 | | 04/16/2024 | $38.60 | | 04/17/2024 | $39.63 | | 04/18/2024 | $38.53 |
|
|
Free CLDX Email Alerts:
